Novo Holdings expands portfolio in cancer diagnostics
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The workshop was conducted as a part of the NITI–State workshop series
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Arco Lab now holds a 50% stake in Neviton
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Subscribe To Our Newsletter & Stay Updated